Stock Track | Caris Life Sciences Soars 5.08% Intraday on Director Share Purchase and Analyst Rating

Stock Track05-12

Caris Life Sciences, Inc. (CAI) saw its stock price soar 5.08% during Tuesday's intraday trading session.

The surge follows a regulatory filing showing that company director Jeff L. Vacirca purchased 31,050 common shares for approximately $501,426.95, increasing his directly held stake to 49,671 shares. Such insider buying is often interpreted by the market as a strong vote of confidence in the company's future prospects.

Additionally, analyst David Westenberg from Piper Sandler maintained a Hold rating on the stock with a price target of $21.00, which may have contributed to positive investor sentiment regarding the stock's valuation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1145960259?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-12 21:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145960259","market":"hk","top_or_hot":-1,"title":"Stock Track | Caris Life Sciences Soars 5.08% Intraday on Director Share Purchase and Analyst Rating","media":"Stock Track","content":"<p>Caris Life Sciences, Inc. (CAI) saw its stock price soar 5.08% during Tuesday's intraday trading session.</p><p>The surge follows a regulatory filing showing that company director Jeff L. Vacirca purchased 31,050 common shares for approximately $501,426.95, increasing his directly held stake to 49,671 shares. Such insider buying is often interpreted by the market as a strong vote of confidence in the company's future prospects.</p><p>Additionally, analyst David Westenberg from Piper Sandler maintained a Hold rating on the stock with a price target of $21.00, which may have contributed to positive investor sentiment regarding the stock's valuation.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Caris Life Sciences Soars 5.08% Intraday on Director Share Purchase and Analyst Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Caris Life Sciences Soars 5.08% Intraday on Director Share Purchase and Analyst Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-12 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Caris Life Sciences, Inc. (CAI) saw its stock price soar 5.08% during Tuesday's intraday trading session.</p><p>The surge follows a regulatory filing showing that company director Jeff L. Vacirca purchased 31,050 common shares for approximately $501,426.95, increasing his directly held stake to 49,671 shares. Such insider buying is often interpreted by the market as a strong vote of confidence in the company's future prospects.</p><p>Additionally, analyst David Westenberg from Piper Sandler maintained a Hold rating on the stock with a price target of $21.00, which may have contributed to positive investor sentiment regarding the stock's valuation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CAI","symbol_name":"Caris Life Sciences, Inc.","start_time":0,"source_url":"","article_id":"1145960259","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145960259","pubTimestamp":1778594347,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Caris Life Sciences, Inc. (CAI) saw its stock price soar 5.08% during Tuesday's intraday trading session.The surge follows a regulatory filing showing that company director Jeff L. Vacirca purchased...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CAI":"Caris Life Sciences, Inc."},"translate_title":"个股追踪|Caris Life Sciences因董事购股及分析师评级盘中大涨5.08%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CAI":1},"content_text":"Caris Life Sciences, Inc. (CAI) saw its stock price soar 5.08% during Tuesday's intraday trading session.The surge follows a regulatory filing showing that company director Jeff L. Vacirca purchased 31,050 common shares for approximately $501,426.95, increasing his directly held stake to 49,671 shares. Such insider buying is often interpreted by the market as a strong vote of confidence in the company's future prospects.Additionally, analyst David Westenberg from Piper Sandler maintained a Hold rating on the stock with a price target of $21.00, which may have contributed to positive investor sentiment regarding the stock's valuation.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1145960259","isCrawlerRequest":true}